Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-03 Purchase | 2023-05-05 9:43 pm | Prairie Operating Co. | CRKR | Breen Michael Martin Director | 916,112 | $0.109 | $99,856 | 1,257,183 (Direct) | View |
| 2023-04-11 Purchase | 2023-04-11 6:59 pm | GT Biopharma Inc. | GTBP | Breen Michael Martin Executive Chairman/Interim CEO | 50,000 | $0.5 | $25,000 | 656,218 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-11 Option Award | 2023-08-15 7:29 pm | N/A N/A | GT Biopharma Inc. | GTBP | Breen Michael Martin Executive Chairman/Interim CEO | 200,000 | $0.287 | 856,218 (Direct) | View |
| 2018-10-16 Option Award | 2023-05-05 9:43 pm | 2018-10-16 2023-10-15 | Prairie Operating Co. | CRKR | Breen Michael Martin Director | 67,500 | $0 | 1,257,183 (Direct) | View |
| 2023-05-03 Option Award | 2023-05-05 9:43 pm | N/A N/A | Prairie Operating Co. | CRKR | Breen Michael Martin Director | 218,571 | $0.175 | 1,257,183 (Direct) | View |
| 2023-01-27 Option Award | 2023-02-01 06:05 am | N/A 2033-01-26 | GT Biopharma Inc. | GTBP | Breen Michael Martin Exec Chairman and Interim CEO | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-07-15 Option Award | 2022-07-19 9:48 pm | 2022-07-15 2032-07-14 | GT Biopharma Inc. | GTBP | Breen Michael Martin Exec. Chair. and Interim CEO | 328,058 | $0 | 656,218 (Direct) | View |
| 2021-02-25 Conversion | 2021-11-12 12:01 pm | 2018-09-07 N/A | GT Biopharma Inc. | GTBP | Breen Michael Martin Director | 130,000 | $0 | 378,160 (Direct) | View |
| 2021-02-16 Option Award | 2021-11-12 12:01 pm | N/A 2031-02-15 | GT Biopharma Inc. | GTBP | Breen Michael Martin Director | 328,058 | $0 | 378,160 (Direct) | View |
| 2021-02-25 Conversion | 2021-11-12 12:01 pm | N/A N/A | GT Biopharma Inc. | GTBP | Breen Michael Martin Director | 50,102 | $3.4 | 378,160 (Direct) | View |
Ownership | 2021-11-12 12:01 pm | 2018-09-07 N/A | GT Biopharma Inc. | GTBP | Breen Michael Martin Director | 0 | $0 | 0 (Direct) | View |